Trump to sign executive order on psychedelic drug used abroad to treat PTSD, via CBS News

This executive order could signal a shift in the U.S. approach to healthcare and drug treatment, which may have broader implications for public health policy and market sentiment. Markets might react to increased volatility in equities and currencies as investors assess potential impacts on pharmaceutical companies and the healthcare sector overall. Keep an eye on how this influences risk appetite and cross-asset flows.